Pennsylvania Code & Bulletin
COMMONWEALTH OF PENNSYLVANIA

• No statutes or acts will be found at this website.

The Pennsylvania Code website reflects the Pennsylvania Code changes effective through 54 Pa.B. 488 (January 27, 2024).

28 Pa. Code § 715.10. Pregnant patients.

§ 715.10. Pregnant patients.

 (a)  A narcotic treatment program may place a pregnant patient, regardless of age, who has had a documented narcotic dependency in the past and who may return to narcotic dependency, on a comprehensive maintenance regime.

   (1)  For these patients, evidence of current physiological dependence on narcotic drugs is not needed if a narcotic treatment physician certifies the pregnancy and, exercising reasonable clinical judgment, finds treatment to be medically justified.

   (2)  Evidence of all findings and the criteria used to determine the findings shall be recorded in the patient’s record by the admitting narcotic treatment physician before the initial dose is administered to the patient.

 (b)  A narcotic treatment program shall give pregnant patients the opportunity for prenatal care either by the narcotic treatment program or by referral to appropriate health-care providers.

 (c)  Counseling records and other appropriate patients records shall reflect the nature of prenatal support provided by the narcotic treatment program.

 (d)  Within 3 months after termination of pregnancy, the narcotic treatment physician shall enter an evaluation of the patient’s treatment status into her record and state whether she should remain in comprehensive maintenance treatment or receive detoxification treatment.

 (e)  A patient who is or becomes pregnant may not be started or continued on LAAM, except by the written order of a narcotic treatment physician who determines that LAAM is the best therapy for that patient.

   (1)  An initial pregnancy test shall be performed for each prospective female patient of childbearing potential before admission to LAAM comprehensive maintenance treatment.

   (2)  A monthly pregnancy test shall be performed thereafter on female patients on LAAM.

 (f)  The narcotic treatment program shall ensure that each female patient is fully informed of the possible risk to her or her unborn child from continued use of illicit drugs and from use of, or withdrawal from a narcotic drug administered or dispensed by the program in comprehensive maintenance or detoxification treatment.



No part of the information on this site may be reproduced for profit or sold for profit.


This material has been drawn directly from the official Pennsylvania Code full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.